✨
AI Summary
- Trends and topics from the J.P. Morgan Healthcare Conference are reviewed.
- Discussion on dealmaking expectations for 2026 in the biopharma sector.
- Analysis of regulatory and commercial outlooks for the coming year.
Guests on This Episode
DW
David Wild
British judge · 168 podcast appearances
JM
Jessica Merrill
3 podcast appearances
MJ
Mandy Jackson
2 podcast appearances